Uveitis is one of the most common causes of vision loss and blindness worldwide. Local
and/or systemic immunosuppression is often required to treat ocular inflammation in …

Uveitis is one of the leading causes of blindness worldwide. Noninfectious uveitis may be
associated with other systemic conditions, such as human leukocyte antigen B27-related …

Introduction Uveitis is a heterogeneous group of inflammatory intraocular disorders that can
lead to blindness, but prompt diagnosis and management can improve visual outcomes and …

Uveitis is a broad term that refers to a large group of eye disorders categorized by
intraocular inflammation, a leading cause of visual impairment. Historically, treatment of …

The management of noninfectious uveitis is constantly evolving. A new “biologic era” in
treatment began after the effectiveness of tumor necrosis factor-alpha blocking drugs was …

Introduction: Treatment of adult, noninfectious uveitis remains a major challenge for
ophthalmologists around the world, especially in regard to recalcitrant cases. It is reported to …

Noninfectious uveitis is a potentially sight-threatening ocular disorder and variable
therapeutic strategies have been proposed. Biologic therapies were introduced as a new …

Non-infectious uveitis is one of the leading causes of preventable blindness worldwide.
Long-term immunosuppressive treatment is generally required to achieve durable control of …

Uveitis is a group of inflammatory eye diseases that cause substantial visual disability and
present challenges to diagnosis and treatment. Immune-mediated subtypes of uveitis must …

Biologic therapies have increased the treatment options for sight-threatening uveitis. Despite
experimental rationale, the lack of evidence from randomized controlled studies limits our …